Tina C. Wan

1.8k total citations
45 papers, 1.6k citations indexed

About

Tina C. Wan is a scholar working on Molecular Biology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Tina C. Wan has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Physiology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Tina C. Wan's work include Adenosine and Purinergic Signaling (21 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Receptor Mechanisms and Signaling (11 papers). Tina C. Wan is often cited by papers focused on Adenosine and Purinergic Signaling (21 papers), Pharmacological Receptor Mechanisms and Effects (11 papers) and Receptor Mechanisms and Signaling (11 papers). Tina C. Wan collaborates with scholars based in United States, Italy and Czechia. Tina C. Wan's co-authors include John A. Auchampach, Laura M. Kreckler, Zhi‐Dong Ge, Elizabeth Gizewski, Dharini van der Hoeven, Garrett J. Gross, Xiaowei Jin, George H. Caughey, Joel Linden and Kenneth A. Jacobson and has published in prestigious journals such as PLoS ONE, Development and Journal of Medicinal Chemistry.

In The Last Decade

Tina C. Wan

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tina C. Wan United States 22 832 749 220 170 170 45 1.6k
Claudia C.S. Chini United States 25 1.1k 1.3× 1.1k 1.4× 126 0.6× 77 0.5× 367 2.2× 40 3.1k
Philip Redpath United Kingdom 14 912 1.1× 983 1.3× 83 0.4× 54 0.3× 111 0.7× 17 2.7k
Laura Formentini Spain 22 201 0.2× 1.3k 1.7× 60 0.3× 56 0.3× 210 1.2× 33 1.9k
Jean-Paul Decuypere Belgium 18 273 0.3× 922 1.2× 124 0.6× 31 0.2× 103 0.6× 28 1.9k
Bong Sook Jhun United States 25 117 0.1× 1.5k 2.0× 112 0.5× 225 1.3× 150 0.9× 51 2.2k
Andrea Lapucci Italy 24 137 0.2× 1.1k 1.4× 107 0.5× 31 0.2× 121 0.7× 54 1.7k
Zully Pedrozo Chile 23 116 0.1× 1.4k 1.9× 387 1.8× 530 3.1× 185 1.1× 46 2.5k
Herman I. May United States 19 225 0.3× 1.5k 2.0× 211 1.0× 904 5.3× 245 1.4× 23 3.1k
Luis A. Rajman United States 8 362 0.4× 1.0k 1.4× 69 0.3× 36 0.2× 192 1.1× 9 2.1k
Sven Geisler Germany 11 149 0.2× 1.9k 2.5× 107 0.5× 55 0.3× 108 0.6× 14 3.2k

Countries citing papers authored by Tina C. Wan

Since Specialization
Citations

This map shows the geographic impact of Tina C. Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina C. Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina C. Wan more than expected).

Fields of papers citing papers by Tina C. Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tina C. Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina C. Wan. The network helps show where Tina C. Wan may publish in the future.

Co-authorship network of co-authors of Tina C. Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Tina C. Wan. A scholar is included among the top collaborators of Tina C. Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina C. Wan. Tina C. Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pavan, Matteo, Tina C. Wan, Marc López‐Cano, et al.. (2025). Bitopic A3 Adenosine Receptor Molecular Probes: Positive Allosteric Modulation and Noncanonical Activation. Journal of Medicinal Chemistry. 68(19). 20717–20740.
2.
Li, Siqi, Tina C. Wan, Christopher Nguyen, et al.. (2025). Transforming Human Amniotic Membrane into Nanoparticles: An Approach for Cardiac Delivery Systems. ACS Applied Bio Materials. 8(9). 8172–8185.
3.
Pavan, Matteo, Veronica Salmaso, Tina C. Wan, et al.. (2024). Lipid Trolling to Optimize A3 Adenosine Receptor-Positive Allosteric Modulators (PAMs). Journal of Medicinal Chemistry. 67(14). 12221–12247. 6 indexed citations
4.
Tosh, Dilip K., Matteo Pavan, Chunxia Cronin, et al.. (2024). 2-Substituted (N)-Methanocarba A3 Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization. ACS Pharmacology & Translational Science. 7(7). 2154–2173. 4 indexed citations
5.
Wan, Tina C., et al.. (2024). Glenn circulation causes early and progressive shunting in a surgical model of pulmonary arteriovenous malformations. Physiological Reports. 12(22). e70123–e70123.
6.
Pavan, Matteo, Veronica Salmaso, Robert F. Keyes, et al.. (2024). Extrahelical Binding Site for a 1H-Imidazo[4,5-c]quinolin-4-amine A3 Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7. Molecular Pharmacology. 105(3). 213–223. 8 indexed citations
7.
Tosh, Dilip K., Veronica Salmaso, Tina C. Wan, et al.. (2023). First Potent Macrocyclic A3 Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences. ACS Pharmacology & Translational Science. 6(9). 1288–1305. 2 indexed citations
8.
Wang, Xinrui, et al.. (2021). Conditional depletion of the acetyltransferase Tip60 protects against the damaging effects of myocardial infarction. Journal of Molecular and Cellular Cardiology. 163. 9–19. 14 indexed citations
9.
Wan, Tina C., et al.. (2018). IL-13 promotes in vivo neonatal cardiomyocyte cell cycle activity and heart regeneration. American Journal of Physiology-Heart and Circulatory Physiology. 316(1). H24–H34. 38 indexed citations
10.
Du, Lili, Zhan-Guo Gao, Silvia Paoletta, et al.. (2017). Species differences and mechanism of action of A3 adenosine receptor allosteric modulators. Purinergic Signalling. 14(1). 59–71. 16 indexed citations
11.
Pan, Jing, Yongik Lee, Qi Zhang, et al.. (2016). Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway. Cancer Prevention Research. 10(2). 133–141. 42 indexed citations
12.
Carlin, Jesse L., Shalini Jain, Elizabeth Gizewski, et al.. (2016). Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms. Neuropharmacology. 114. 101–113. 56 indexed citations
13.
Nayak, Shraddha, Abdul H. Khan, Tina C. Wan, et al.. (2015). Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension. Purinergic Signalling. 11(4). 519–531. 10 indexed citations
14.
Chandrasekera, P. Charukeshi, Tina C. Wan, Elizabeth Gizewski, John A. Auchampach, & Robert D. Lasley. (2013). Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling. Cellular Signalling. 25(4). 736–742. 31 indexed citations
15.
Auchampach, John A., Elizabeth Gizewski, Tina C. Wan, et al.. (2009). Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor. Biochemical Pharmacology. 79(7). 967–973. 21 indexed citations
16.
Kreckler, Laura M., Elizabeth Gizewski, Tina C. Wan, & John A. Auchampach. (2009). Adenosine Suppresses Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Murine Macrophages through a Protein Kinase A- and Exchange Protein Activated by cAMP-Independent Signaling Pathway. Journal of Pharmacology and Experimental Therapeutics. 331(3). 1051–1061. 38 indexed citations
17.
Hoeven, Dharini van der, Tina C. Wan, & John A. Auchampach. (2008). Activation of the A3 Adenosine Receptor Suppresses Superoxide Production and Chemotaxis of Mouse Bone Marrow Neutrophils. Molecular Pharmacology. 74(3). 685–696. 66 indexed citations
18.
Kreckler, Laura M., Tina C. Wan, Zhi‐Dong Ge, & John A. Auchampach. (2006). Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor. Journal of Pharmacology and Experimental Therapeutics. 317(1). 172–180. 179 indexed citations
19.
Auchampach, John A., Xiaowei Jin, Jeannine Moore, et al.. (2004). Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs. Journal of Pharmacology and Experimental Therapeutics. 308(3). 846–856. 36 indexed citations
20.
Auchampach, John A., Xiaowei Jin, Tina C. Wan, George H. Caughey, & Joel Linden. (1997). Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor. Molecular Pharmacology. 52(5). 846–860. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026